Diagnostic Performance of Exome Sequencing in Autism Spectrum Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-06-12

Study Completion Date

2021-10-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of the diagnostic performance of exome sequencing in a prospective series of patients with autism spectrum disorders (ASD).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Epidemiological Studies of Eating Disorders in Gifted Dance Students (2nd Year).

NCT00173160

Eating Disorders

COMPLETED

Gastrointestinal Tolerance Assessment of T2309

NCT04596605

Healthy Adult Subjects

COMPLETED NA

Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Patients With Non-coeliac Gluten Sensitivity

NCT03798249

NCGS Gluten

UNKNOWN NA

Gluten for Autism Spectrum Disorders

NCT02280746

Autism Spectrum Disorders

UNKNOWN NA

Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up

NCT04789993

Type 1 Diabetes Autoimmune Diseases Hashimoto Disease +4 more

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Spectrum Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with ASD who has been previously diagnosed by an expert center according to the DSM5 criteria using standardized instruments (ADOS, ADI-R), referred to genetic consultation by the psychiatrist who performed the clinical diagnosis, according to the recommendations of the HAS, and requesting a genetic analysis for medical purposes in this context.
* Patient over 3 years old
* Patient affiliated to a social security scheme
* For minor patients: Holders of the exercise of parental authority who have read and understood the newsletter and signed the consent form
* For a major patient: Major patient who has read and understood the newsletter and signed the consent form
* Supervised minor / minor patient: Legal representative who has read and understood the newsletter and signed the consent form
* Major patient under guardianship: Major patient assisted by his curator or by the judge having read and understood the newsletter and signed the consent form
* DNA of the patient and parents available

Exclusion Criteria

* Patient who has already benefited from exome sequencing
* Person deprived of liberty by an administrative or judicial decision
* Pregnant or lactating woman

Eligible Sex

ALL

Accepts Healthy Volunteers

No